Table 1 Socio-demographic and clinical characteristics of participants.
From: Measurement properties from the Brazilian Portuguese version of the QUIP-RS
Feature | Mean ± SD or % | Range |
|---|---|---|
Gender | ||
Men | 33 (62.3%) | |
Women | 20 (37.7%) | |
Age (years) | 68.3 ± 10.9 | 45–89 |
Marital status | ||
Single | 8 (15.1%) | |
Married, divorced, or widowed | 45 (84.9%) | |
Schooling (years) | 9.1 ± 5.3 | 0–22 |
Smoking | 0 (0%) | |
Family history of problems with gambling | 5 (9.4%) | |
Problems with gambling in the family currently | 0 (0%) | |
Family history of alcohol abuse | 20 (37.7%) | |
Alcoholism | 12 (2.6%) | |
Prefer not to say | 1 (1.9%) | |
Diagnosis of PD (years) | 6.0 ± 5.2 | 0.02–26 |
Modified H & Y staging (median) | 2.5 | |
1, 1.5, 2, 2.5 (Mild) | 33 (62.3%) | |
3 (Moderate) | 16 (30.2%) | |
4 (Severe) | 4 (7.5%) | |
MMSE | 24.7 ± 2.9 | |
UPDRS III | 22.0 ± 12.5 | 6–64 |
UPDRS IV | 2.3 ± 2.4 | 0–10 |
Deep-brain stimulation | 0 (0%) | |
Medication in use | ||
Levodopa LEDD (mg/day) | 576.1 ± 279.0 | 0–1142.8 |
LEDD dopamine agonist (mg/day) | 69.81 ± 78.29 | 0–210 |
Patients on dopamine agonist | 25 (47%) | |
TOTAL LEDD (mg/day) | 662.8 ± 317.7 | 0–1390.7 |
Use of amantadine | 15 (28.3%) | |
Use of antidepressant | 12 (22.6%) | |
Frequency for symptoms indicative of ICDs | 26 (49.1%) | |
Total score in Brazilian Portuguese QUIP-RS | 6.8 ± 7.9 | 0–26 |
